Home
ARK Investment Management reported a 7.25% stake in Recursion Pharmaceuticals RXRX · 37,316,856 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 7.25%
- Last report
- 8.47% · filed 25/02/14
- Shares held
- 37,316,856 sh
- Class
- Class A Common Stock
- Event date
- 25/12/31
- Filed
- 26/02/03
7.25% stake · −1.2pp from the last report
- Stake
- 7.25%
- Last report
- 8.47%
- Since last report
- −1.2pp
Recursion Pharmaceuticals trades, last 26 weeks
What else happened in Recursion Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30ARK Investment Management's other 5% stake reports
- ARK Investment Management
5% stakeTwist Bioscience
5% stakeTwist Bioscience
TWST
5.11% stake
3,385,850 sh
5.11% stake
Filed 09/08
- ARK Investment Management
5% stake10x Genomics
5% stake10x Genomics
TXG
8.56% stake
10,003,058 sh
8.56% stake
Filed 08/14
- ARK Investment Management
5% stakeTwist Bioscience
5% stakeTwist Bioscience
TWST
7.31% stake
4,549,803 sh
7.31% stake
Filed 08/14
- ARK Investment Management
5% stakeBeam Therapeutics
5% stakeBeam Therapeutics
BEAM
9.95% stake
10,234,862 sh
9.95% stake
Filed 08/14
- ARK Investment Management
5% stakePacific Biosciences of California
5% stakePacific Biosciences of California
PACB
9.59% stake
29,781,416 sh
9.59% stake
Filed 08/14
